Loading...

Home
ETF
VTRS

VTRS

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

VTRS News

Viatris to Report Q2 2026 Financial Results on August 6

Jul 01 2026PRnewswire

FDA to Announce Multiple Therapy Decisions in July

Jul 01 2026NASDAQ.COM

Viatris Reports Successful Phase 3 Results for Nefecon in IgAN

Jun 29 2026seekingalpha

Viatris Reports Positive Phase 3 Results for IgAN Drug VR-205

Jun 29 2026NASDAQ.COM

Pfizer Dismissed from Antitrust Lawsuit Over Generic Drug Pricing

Jun 24 2026Newsfilter

Viatris Sales Trends Improve, Valuation Potential Rises

Jun 04 2026CNBC

Viatris Receives Overweight Rating and Price Target

May 27 2026Yahoo Finance

Mark Cuban to Join Trump for Generic Drug Announcement

May 18 2026seekingalpha

Viatris' NDA for Fast-Acting Meloxicam Accepted by FDA

May 18 2026Newsfilter

HHS Considers Restrictions on Antidepressant Use Amid Mental Health Crisis

May 08 2026seekingalpha

Viatris to Present at Bank of America Healthcare Conference

May 07 2026PRnewswire

Viatris Reports Strong Q1 2026 Earnings with $3.5 Billion Revenue

May 07 2026seekingalpha

Viatris Reaffirms Full-Year Outlook, Shares Surge

May 07 2026seekingalpha

Viatris Executive Anticipates Mid to High Single-Digit Revenue Growth in Greater China by 2026 - Conference Call

May 07 2026moomoo

Viatris Q1 Earnings Exceed Expectations

May 07 2026seekingalpha

Viatris Set to Report Q1 Earnings Amid Pricing Pressures

May 06 2026seekingalpha